DexCom (DXCM) Could Be 32% Undervalued Following Health Canada G7 Pregnancy Clearance
How Pregnancy Device Approval At DexCom (DXCM) Has Changed Its Investment Story
Is DexCom Stock Cheaper Now That Its Multiple Has Fallen?
Dexcom Announces Upcoming Conference Presentation
Advancing type 1 diabetes care during pregnancy: a Canadian first
What Is Behind The Move In DexCom Stock?
He went from washing lab equipment for $10 an hour to leading a $30 billion healthcare company. His advice to Gen Z: Raise your hand
Dexcom Invites the Global Diabetes Community to Share Their Stories Through A Letter to Diabetes Campaign
Dexcom lifts 2026 revenue outlook after positive Q3
DexCom, Inc. 2026 Q3 - Results - Earnings Call Presentation
DexCom: Improving Patient Access Makes It A Long-Term Buy
DXCM Q3 deep dive: clinical momentum and new product launches support growth trajectory
DexCom (DXCM) Stock Looks Below Fair Value on Cash Flow
DexCom (DXCM) Brings Its 15 Day Glucose Monitor To Canada
Canaccord Genuity Maintains Buy on DexCom, Raises Price Target to $97
JP Morgan Maintains Neutral on DexCom, Raises Price Target to $85
DexCom Q3 Results, Higher Revenue Guidance Point to Stronger 2027, RBC Says
Dexcom (DXCM) Q3 2026 Earnings Call Transcript
DexCom, Inc. Q3 2026 Earnings Call Summary
Barclays Maintains Overweight on DexCom, Raises Price Target to $120
Sign up for free to unlock this feature.
Creating your account...
Your account has been created. Redirecting...
Loading...
This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.